Pluri Inc. Cost of Revenue
Pluri Inc. (PLUR) reported Cost of Revenue of $563.00 thousand for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-10.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2026-09-10
- Pluri Inc. cost of revenue for the quarter ending 2026-06-30 was $139.00K, a 27.23% decline year-over-year.
- Pluri Inc. cost of revenue for the quarter ending 2026-03-31 was $111.00K, a 61.86% decline year-over-year.
- Pluri Inc. cost of revenue for the quarter ending 2025-12-31 was $112.00K, a 51.35% increase year-over-year.
- Pluri Inc. cost of revenue for the quarter ending 2025-09-30 was $201.00K, a 59.52% increase year-over-year.
- Pluri Inc. cost of revenue for fiscal 2026 was $563.00K, a 17.45% decline from fiscal 2025.
- Pluri Inc. cost of revenue for fiscal 2025 was $682.00K, a 16950.00% increase from fiscal 2024.
- Pluri Inc. cost of revenue for fiscal 2024 was $4.00K, a 55.56% decline from fiscal 2023.
- Pluri Inc. cost of revenue for fiscal 2023 was $9.00K.
| Period end | Cost of Revenue 3 month | Cost of Revenue 3 month as first filed | Cost of Revenue 6 month | Cost of Revenue 6 month as first filed | Cost of Revenue 9 month | Cost of Revenue 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $139.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-10 | $250.00K derived: sum of 2 quarters · filed 2026-09-10 | $362.00K derived: sum of 3 quarters · filed 2026-09-10 | $563.00K 10-K · filed 2026-09-10 | ||
| 2026-03-31 | $111.00K 10-Q · filed 2026-05-14 | $223.00K derived: sum of 2 quarters · filed 2026-05-14 | $424.00K 10-Q · filed 2026-05-14 | $615.00K derived: sum of 4 quarters · filed 2026-09-10 | ||
| 2025-12-31 | $112.00K 10-Q · filed 2026-02-12 | $313.00K 10-Q · filed 2026-02-12 | $504.00K derived: sum of 3 quarters · filed 2026-09-10 | $795.00K derived: sum of 4 quarters · filed 2026-09-10 | ||
| 2025-09-30 | $201.00K 10-Q · filed 2025-11-12 | $392.00K derived: sum of 2 quarters · filed 2026-09-10 | $683.00K derived: sum of 3 quarters · filed 2026-09-10 | $757.00K derived: sum of 4 quarters · filed 2026-09-10 | ||
| 2025-06-30 | $191.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-10 | $482.00K derived: sum of 2 quarters · filed 2026-09-10 | $556.00K derived: sum of 3 quarters · filed 2026-09-10 | $682.00K 10-K · filed 2026-09-10 | ||
| 2025-03-31 | $291.00K 10-Q · filed 2026-05-14 | $365.00K derived: sum of 2 quarters · filed 2026-05-14 | $491.00K 10-Q · filed 2026-05-14 | |||
| 2024-12-31 | $74.00K 10-Q · filed 2026-02-12 | $200.00K 10-Q · filed 2026-02-12 | ||||
| 2024-09-30 | $126.00K 10-Q · filed 2025-11-12 | |||||
| 2024-06-30 | $4.00K 10-K · filed 2025-09-17 | |||||
| 2023-06-30 | $9.00K 10-K · filed 2024-09-18 | |||||
| 2020-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-06 | $1.00K derived: sum of 2 quarters · filed 2021-05-06 | $1.00K 10-Q · filed 2021-05-06 | |||
| 2019-12-31 | $1.00K 10-Q · filed 2021-02-08 | $1.00K 10-Q · filed 2021-02-08 | ||||
| 2019-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-10 | $0.00 derived: sum of 2 quarters · filed 2020-09-10 | $2.00K derived: sum of 3 quarters · filed 2020-09-10 | $2.00K 10-K · filed 2020-09-10 | ||
| 2019-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-11 | $2.00K derived: sum of 2 quarters · filed 2020-05-11 | $2.00K 10-Q · filed 2020-05-11 | |||
| 2018-12-31 | $2.00K 10-Q · filed 2020-02-06 | $2.00K 10-Q · filed 2020-02-06 | ||||
| 2018-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-10 | $0.00 derived: sum of 2 quarters · filed 2020-09-10 | $2.00K derived: sum of 3 quarters · filed 2020-09-10 | $2.00K 10-K · filed 2020-09-10 | ||
| 2018-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-06 | $2.00K derived: sum of 2 quarters · filed 2019-05-06 | $2.00K 10-Q · filed 2019-05-06 | |||
| 2017-12-31 | $2.00K 10-Q · filed 2019-02-06 | $2.00K 10-Q · filed 2019-02-06 | ||||
| 2016-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-12 | $0.00 derived: sum of 2 quarters · filed 2018-09-12 | $97.00K derived: sum of 3 quarters · filed 2018-09-12 | $100.00K 10-K · filed 2018-09-12 | ||
| 2016-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-08 | $97.00K derived: sum of 2 quarters · filed 2017-05-08 | $100.00K 10-Q · filed 2017-05-08 | $103.00K derived: sum of 4 quarters · filed 2017-09-07 | ||
| 2015-12-31 | $97.00K 10-Q · filed 2017-02-08 | $100.00K 10-Q · filed 2017-02-08 | $103.00K derived: sum of 3 quarters · filed 2017-09-07 | $106.00K derived: sum of 4 quarters · filed 2017-09-07 | ||
| 2015-09-30 | $3.00K 10-Q · filed 2016-11-07 | $6.00K derived: sum of 2 quarters · filed 2017-09-07 | $9.00K derived: sum of 3 quarters · filed 2017-09-07 | $13.00K derived: sum of 4 quarters · filed 2017-09-07 | ||
| 2015-06-30 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-07 | $6.00K derived: sum of 2 quarters · filed 2017-09-07 | $10.00K derived: sum of 3 quarters · filed 2017-09-07 | $13.00K 10-K · filed 2017-09-07 | ||
| 2015-03-31 | $3.00K 10-Q · filed 2016-05-09 | $7.00K derived: sum of 2 quarters · filed 2016-05-09 | $10.00K 10-Q · filed 2016-05-09 | $12.00K derived: sum of 4 quarters · filed 2016-09-07 | ||
| 2014-12-31 | $4.00K 10-Q · filed 2016-02-08 | $7.00K 10-Q · filed 2016-02-08 | $9.00K derived: sum of 3 quarters · filed 2016-09-07 | $12.00K derived: sum of 4 quarters · filed 2016-09-07 | ||
| 2014-09-30 | $3.00K 10-Q · filed 2015-11-05 | $5.00K derived: sum of 2 quarters · filed 2016-09-07 | $8.00K derived: sum of 3 quarters · filed 2016-09-07 | $11.00K derived: sum of 4 quarters · filed 2016-09-07 | ||
| 2014-06-30 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-07 | $5.00K derived: sum of 2 quarters · filed 2016-09-07 | $8.00K derived: sum of 3 quarters · filed 2016-09-07 | $11.00K 10-K · filed 2016-09-07 | ||
| 2014-03-31 | $3.00K 10-Q · filed 2015-05-06 | $6.00K derived: sum of 2 quarters · filed 2015-05-06 | $9.00K 10-Q · filed 2015-05-06 | $11.00K derived: sum of 4 quarters · filed 2015-09-09 | ||
| 2013-12-31 | $3.00K 10-Q · filed 2015-02-05 | $6.00K 10-Q · filed 2015-02-05 | $8.00K derived: sum of 3 quarters · filed 2015-09-09 | $14.00K derived: sum of 4 quarters · filed 2015-09-09 | ||
| 2013-09-30 | $3.00K 10-Q · filed 2014-11-06 | $5.00K derived: sum of 2 quarters · filed 2015-09-09 | $11.00K derived: sum of 3 quarters · filed 2015-09-09 | $17.00K derived: sum of 4 quarters · filed 2015-09-09 | ||
| 2013-06-30 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-09 | $8.00K derived: sum of 2 quarters · filed 2015-09-09 | $14.00K derived: sum of 3 quarters · filed 2015-09-09 | $20.00K 10-K · filed 2015-09-09 | ||
| 2013-03-31 | $6.00K 10-Q · filed 2014-05-08 | $12.00K derived: sum of 2 quarters · filed 2014-05-08 | $18.00K 10-Q · filed 2014-05-08 | $21.00K derived: sum of 4 quarters · filed 2014-09-11 | ||
| 2012-12-31 | $6.00K 10-Q · filed 2014-02-05 | $6.00 10-Q · filed 2013-01-31 | $12.00K 10-Q · filed 2014-02-05 | $12.00 10-Q · filed 2013-01-31 | $15.00K derived: sum of 3 quarters · filed 2014-09-11 | $21.00K derived: sum of 4 quarters · filed 2014-09-11 |
| 2012-09-30 | $6.00K 10-Q · filed 2013-11-05 | $9.00K derived: sum of 2 quarters · filed 2014-09-11 | $15.00K derived: sum of 3 quarters · filed 2014-09-11 | $15.01K derived: sum of 4 quarters · filed 2014-09-11 | ||
| 2012-06-30 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-11 | $9.00K derived: sum of 2 quarters · filed 2014-09-11 | $9.01K derived: sum of 3 quarters · filed 2014-09-11 | $21.00K 10-K · filed 2014-09-11 | ||
| 2012-03-31 | $6.00K 10-Q · filed 2013-05-08 | $6.01K derived: sum of 2 quarters · filed 2013-05-08 | $18.00K 10-Q · filed 2013-05-08 | |||
| 2011-12-31 | $7.00 10-Q · filed 2013-01-31 | $12.00 10-Q · filed 2013-01-31 | ||||
| 2011-09-30 | $5.00K 10-Q · filed 2012-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |